ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1906

Bayesian Algorithm to Identify Osteoarthritis in Administrative Health Data Without Requiring Chart Review

S. Reza Jafarzadeh1, Sarah Tilley1, Anup Arvind1 and David Felson2, 1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 2Boston University, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Biostatistics, Diagnostic criteria, Epidemiology, Health Services Research, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) is the most prevalent arthritis and a significant contributor to Years Lived with Disability. Administrative health data are widely used to study OA prevalence, treatments, comorbidities, and healthcare costs. However, the use of these data is limited by inadequate case ascertainment. Existing algorithms have low sensitivity (~49%) or specificity (~60-95%), resulting in biased samples. Chart review-based validation is imperfect, not fully generalizable across datasets, and infeasible for large populations. We aimed to develop a Bayesian algorithm to improve OA case ascertainment in administrative health data without requiring chart review.

Methods: We developed a latent class Bayesian multinomial model to estimate the probability of OA in an individual using a “No Reference Standard” approach. This methodology allows estimating sensitivity, specificity, and predictive values using observed true positive and false positive fractions and unobserved (latent) true prevalence. We included all individuals aged 18-65 with continuous enrollment in Merative MarketScan Research Databases 2018-2019. We excluded those with a history of psoriasis, rheumatoid arthritis, fibromyalgia, or knee replacement. The algorithm included all possible combinations of four data elements: knee OA diagnosis, knee pain indication/NSAID/opioid prescription, knee imaging, and meniscal/ACL tear.

Results: Our Bayesian algorithm estimated OA probabilities for 8,666,958 eligible individuals based on all data element combinations. The probability of a person having OA was estimated to be ~99% in 8 (out of 16) combinations of the data element outcomes (Table 1). The probability of OA for a person coded for OA, but not coded for other data elements was less than 1%. Having an OA code and at least one more positive data element yielded >70% probability of OA.

Conclusion: Our Bayesian algorithm improves OA identification in administrative data without requiring chart review via selecting the most informative data element combinations that provide highest predictive values. This approach is applicable to other conditions where reference standards are unavailable.

Supporting image 1

Table 1. Estimated probability of OA in an individual (i.e., predictive values) for all 16 combinations of data element outcomes in Merative MarketScan Research Databases 2018_2019.

T1: Knee OA diagnosis claim (ICD_10) between 01/01/2018 and 12/31/2019,
T2: Claim for knee pain, or NSAIDs/opioid prescription between 01/01/2018 and 12/31/2019,
T3: Knee imaging (X-ray/MRI) claim between 10/1/2015 and 12/31/2019,
T4: Meniscal/ACL tear claim between 10/1/2015 and 12/31/2019.


Disclosures: S. Jafarzadeh: None; S. Tilley: None; A. Arvind: None; D. Felson: None.

To cite this abstract in AMA style:

Jafarzadeh S, Tilley S, Arvind A, Felson D. Bayesian Algorithm to Identify Osteoarthritis in Administrative Health Data Without Requiring Chart Review [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/bayesian-algorithm-to-identify-osteoarthritis-in-administrative-health-data-without-requiring-chart-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bayesian-algorithm-to-identify-osteoarthritis-in-administrative-health-data-without-requiring-chart-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology